CD40LG and ulcerative colitis: Although excluding individuals with reported diagnoses of autoimmune diseases of ulcerative colitis, Crohn’s disease, or rheumatoid arthritis or removal of those with positive biomarkers for rheumatoid arthritis (anti-CCP3, RF-IgA, and RF-IgM) did not significantly change the risk of NHL or DLBCL, we did not have data for all autoimmune diseases, medications for autoimmune diseases, or immunosuppressive treatment.